ARAY - Accuray Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.00
+0.08 (+1.91%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close3.92
Open4.00
Bid3.90 x 1000
Ask4.20 x 2200
Day's range3.95 - 4.15
52-week range3.60 - 6.15
Volume1,138,237
Avg. volume530,756
Market cap342.552M
Beta2.41
PE ratio (TTM)N/A
EPS (TTM)-0.34
Earnings date20 Aug 2018 - 24 Aug 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.20
Trade prices are not sourced from all markets
  • Accuray's Radixact Gets AERB Nod in India, Prospects Solid
    Zacksyesterday

    Accuray's Radixact Gets AERB Nod in India, Prospects Solid

    The Atomic Energy Regulatory Board (AERB) approves Accuray's (ARAY) Radixact X9 in India; exposes the company to AI and Mechatronic trends.

  • At US$04.325, Is It Time To Buy Accuray Incorporated (NASDAQ:ARAY)?
    Simply Wall St.2 days ago

    At US$04.325, Is It Time To Buy Accuray Incorporated (NASDAQ:ARAY)?

    Accuray Incorporated (NASDAQ:ARAY), a medical equipment company based in United States, received a lot of attention from a substantial price movement on the NasdaqGS over the last few months, increasingRead More...

  • New Strong Sell Stocks for June 11th
    Zacks12 days ago

    New Strong Sell Stocks for June 11th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Here's Why You Should Sell Accuray (ARAY) Stock Right Now
    Zacks18 days ago

    Here's Why You Should Sell Accuray (ARAY) Stock Right Now

    Regulatory issues regarding Onrad, intense competition in the radiation oncology market and unfavorable foreign exchange rate are significant challenges for Accuray (ARAY).

  • New Strong Sell Stocks for June 4th
    Zacks19 days ago

    New Strong Sell Stocks for June 4th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Accuray (ARAY) Down 13.7% Since Earnings Report: Can It Rebound?
    Zacks24 days ago

    Accuray (ARAY) Down 13.7% Since Earnings Report: Can It Rebound?

    Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Why Accuray, Cincinnati Bell, and Chesapeake Energy Slumped Today
    Motley Fool29 days ago

    Why Accuray, Cincinnati Bell, and Chesapeake Energy Slumped Today

    Find out which company dealt with weak earnings.

  • New Strong Sell Stocks for May 23rd
    Zackslast month

    New Strong Sell Stocks for May 23rd

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • New Strong Sell Stocks for May 17th
    Zackslast month

    New Strong Sell Stocks for May 17th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • GlobeNewswirelast month

    Factors of Influence in 2018, Key Indicators and Opportunity within Accuray, Torchmark, Carlisle Companies, CVR Refining, LP, Whirlpool, and CoreLogic — New Research Emphasizes Economic Growth

    NEW YORK, May 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Accuray ...

  • PR Newswirelast month

    Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy Systems

    SUNNYVALE, Calif., May 9, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the company has signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact® and CyberKnife® M6™ Systems, building on a 13-year relationship designed to expand access to advanced, life-saving technology for more cancer patients. The next-generation systems will replace existing Accuray devices as well as competitive conventional linear accelerators.

  • PR Newswire2 months ago

    Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

    SUNNYVALE, Calif., May 4, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Patrick Spine, the company's new Senior Vice President, Human Resources.  As a material inducement to Mr. Spine joining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), the Board of Directors of the company unanimously approved granting Mr. Spine (i) an award of 18,750 restricted stock units covering shares of the company's common stock, (ii) a stock option to purchase 46,875 shares of the company's common stock, and (iii) an award of a target number of 37,500 performance units covering shares of the company's common stock, in each case effective as of April 30, 2018 (collectively, the "Inducement Awards").

  • Accuray (ARAY) Q3 Loss Wider Than Estimates, Revenues Top
    Zacks2 months ago

    Accuray (ARAY) Q3 Loss Wider Than Estimates, Revenues Top

    Radixact System and major software overhaul drive Accuray (ARAY) in Q3.

  • Associated Press2 months ago

    Accuray: Fiscal 3Q Earnings Snapshot

    The Sunnyvale, California-based company said it had a loss of 10 cents per share. The radiation oncology company posted revenue of $99.8 million in the period. Accuray expects full-year revenue in the ...

  • PR Newswire2 months ago

    Accuray Reports Third Fiscal Quarter Results

    SUNNYVALE, Calif. , April 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter ended March 31, 2018 . Fiscal Third Quarter Highlights ...

  • PR Newswire2 months ago

    Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37

    SUNNYVALE, Calif., April 17, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and software solutions at the 37th annual European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain. The meeting, to be held April 20-24, 2018, will attract more than 3,000 radiation oncology professionals who will gather to gain information and insights on the latest developments in radiation therapy. Accuray will be in attendance at booth #1700, sharing information on new treatment approaches and providing opportunities for conversations about how the company's innovative CyberKnife® and Radixact® Systems, and advanced software solutions, can help improve the radiation therapy treatment experience for clinicians and their patients.

  • PR Newswire2 months ago

    Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37

    Accuray Incorporated (ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and software solutions at the 37th annual European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain. The meeting, to be held April 20-24, 2018, will attract more than 3,000 radiation oncology professionals who will gather to gain information and insights on the latest developments in radiation therapy. Accuray will be in attendance at booth #1700, sharing information on new treatment approaches and providing opportunities for conversations about how the company's innovative CyberKnife® and Radixact® Systems, and advanced software solutions, can help improve the radiation therapy treatment experience for clinicians and their patients.

  • PR Newswire2 months ago

    Accuray To Report Fiscal 2018 Third Quarter Financial Results On April 30, 2018

    SUNNYVALE, Calif. , April 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2018 on Monday, April 30, 2018 after the market close, following ...

  • Accuray Radixact Picked by India's Apollo for Cancer Treatment
    Zacks3 months ago

    Accuray Radixact Picked by India's Apollo for Cancer Treatment

    Accuray's (ARAY) flagship Radixact radiotherapy platform to help in cancer treatment at Apollo Hospital Group in New Delhi and Chennai, India.

  • Accuray's CyberKnife Treats First Patient at Erasmus MC
    Zacks3 months ago

    Accuray's CyberKnife Treats First Patient at Erasmus MC

    Accuray (ARAY) and Erasmus MC partner to develop CyberKnife platform to simplify diagnosis of oligometastatic diseases.

  • Accuray Banks on Acquisition & Partnership Amid Competition
    Zacks3 months ago

    Accuray Banks on Acquisition & Partnership Amid Competition

    Accuray's (ARAY) partnerships with Premier and Amerinet are expected to help the company gain significant penetration in hospitals and oncology centers.

  • PR Newswire3 months ago

    Apollo Hospitals in India to Acquire Two Accuray Radixact® Systems

    SUNNYVALE, Calif., March 28, 2018 /PRNewswire/ -- Personalized, precise, radiation treatments will soon be available to more cancer patients in India. Accuray Incorporated (ARAY) announced today that the company has signed an agreement with the Apollo Hospitals Group in Chennai and New Delhi, India, for the acquisition of two Radixact® Systems, radiation therapy devices that have been proven to deliver highly accurate treatments for a broad range of tumors anywhere in the body. The installation of these systems, one replacing a conventional linear accelerator and the other in a new vault, will expand access to state-of-the-art cancer treatment technology for the people of India.

  • PR Newswire3 months ago

    Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy with the CyberKnife® System

    SUNNYVALE, Calif. and ROTTERDAM, Netherlands, March 27, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) and Erasmus MC, the largest university medical center in the Netherlands, announced today that the first patient has been successfully treated using an online-adaptive (OA) approach together with the CyberKnife® System. The patient, treated for oligometastases in the pelvic region, is part of a new clinical trial conducted at Erasmus MC evaluating OA stereotactic body radiation therapy (SBRT) delivered by the CyberKnife platform. "At Erasmus MC our goal is to use innovative approaches to provide customized, effective treatments that help extend or improve the quality of life of people diagnosed with cancer, regardless of the stage of their cancer diagnosis," said J.J. Nuyttens, MD, PhD, radiation oncologist, department of radiation oncology, Erasmus MC.

  • Accuray Gains on Radixact Unit, Solid Geographical Foothold
    Zacks3 months ago

    Accuray Gains on Radixact Unit, Solid Geographical Foothold

    Radixact and TomoTherapy along with solid global prospects are the key catalysts for Accuray (ARAY).

  • Cogentix Medical (CGNT) Looks Good: Stock Adds 13.3% in Session
    Zacks3 months ago

    Cogentix Medical (CGNT) Looks Good: Stock Adds 13.3% in Session

    The shares of Cogentix Medical (CGNT) rose over 13% yesterday after reports surfaced that the company is going to be acquired by Laborie Medical Technologies.